B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion (Q43418649)

23 November 2017

title

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion (English)

1 reference

23 November 2017

Yu Zhang

1 reference

23 November 2017

Yair Eliav

1 reference

23 November 2017

Seung-Uon Shin

1 reference

23 November 2017

Taylor H Schreiber

1 reference

23 November 2017

Eckhard R Podack

1 reference

23 November 2017

Tamar Tadmor

1 reference

23 November 2017

Joseph D Rosenblatt

1 reference

23 November 2017

publication date

8 July 2012

1 reference

Cancer Immunology, Immunotherapy

23 November 2017

published in

1 reference

23 November 2017

1 reference

23 November 2017

1 reference

23 November 2017

page(s)

87-99

1 reference

Regulatory role of mature B cells in a murine model of inflammatory bowel disease.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Prevention of arthritis by interleukin 10-producing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Inhibitory effects of B cells on antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

B cells inhibit induction of T cell-dependent tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Antibodies against p53 are associated with poor prognosis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Inverse correlation between NKG2D expression on CD8+ T cells and the frequency of CD4+CD25+ regulatory T cells in patients with esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1313-6

10.1007/S00262-012-1313-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

23 November 2017

1043404730

0 references

1 reference